Form 4 for CVS CVS Health
Accepted 2025-11-21 00:00:00 ET · period of report 2025-11-20 · accession 0000064803-25-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-21 | 2025-11-20 | CVS | Finucane Anne A. | Dir | A - Grant | $76.04 | +591 | 591 | New | +$44.9K |
| D | 2025-11-21 | 2025-11-20 | CVS | Finucane Anne A. | Dir | A - Grant | $76.04 | +1,775 | 16.5K | +12% | +$135.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-20 | A | A | 591 | $76.04 | 591 | D | — | — | (F1) Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. |
| 2 | Derivative | Deferred Stock Units | 2025-11-20 | A | A | 1,775.38 | $76.04 | 16,530.06 | D | $0.00 · — to — | 1,775.38 Common Stock | (F2) Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. (F3) Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. |